Entering text into the input field will update the search result below

Diffusion Pharma short of Nasdaq listing requirements

May 26, 2017 4:20 PM ETCervoMed Inc. (CRVO) StockCRVOBy: Douglas W. House, SA News Editor
  • Nasdaq notifies Diffusion Pharmaceuticals (NASDAQ:DFFN) that it no longer meets listing requirements for minimum market value ($35M) and minimum stockholders' equity ($2.5M). The company has 180 days to address the issues or face possible delisting.

Recommended For You

More Trending News

About CRVO Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CRVO--
CervoMed Inc.